Contracts Finder · Award
PHE - Corporate - Foetal Anomaly Screening
A public procurement published by Public Health England via Contracts Finder.
- £39.2k
- Award value
- —
- Tender value
- 1
- Suppliers
- 1
- Awards
- 1
- Notices
- Award
- Stage
Overview
Use of quadruple testing to detect trisomy 18 and alpha-fetoprotein as an adjunct to ultrasound to detect spina bifida and anencephaly in the second trimester
Key details
- Source
- Contracts Finder
- Lifecycle stage
- Award
- Status
- complete
- CPV classification
- 75122000 — Administrative healthcare services
- Currency
- GBP
- Total award value
- £39,248
- Tender value
- —
- First published
- 26 Mar 2020
- Last updated
- 26 Mar 2020
Awards
1 award recorded on this procurement.
| Supplier | Companies House | Awarded | Status | Value |
|---|---|---|---|---|
| Costello Medical Consulting Ltd | 06746770 | 25 Mar 2020 | active | £39.2k |
Notice timeline
Every published notice in this procurement's lifecycle.
All suppliers
Frameworks & programmes
More from Public Health England
FAQs about this procurement
Who is the buyer for "PHE - Corporate - Foetal Anomaly Screening"?
PHE - Corporate - Foetal Anomaly Screening is a UK public-sector procurement published by Public Health England via Contracts Finder.
Has "PHE - Corporate - Foetal Anomaly Screening" been awarded?
Yes — 1 award is recorded, with a reported total value of £39,248. The current lifecycle stage is "Award".
Which suppliers are involved in "PHE - Corporate - Foetal Anomaly Screening"?
1 supplier is linked: Costello Medical Consulting Ltd.
What is "PHE - Corporate - Foetal Anomaly Screening" worth?
The reported award value is £39,248.
When was "PHE - Corporate - Foetal Anomaly Screening" published?
It was first published on 26 Mar 2020 and last updated on 26 Mar 2020, across 1 notice.
Track procurements like this one
Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.
Get in touch with Enable